The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

AstraZeneca has overhauled its local management in China, replacing Michael Lai with Alex Lin as the country's general ...

AstraZeneca restructures its China operations following leadership scandals and sales challenges, appointing new executives ...

From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...

The conversion of Calquence’s accelerated approval in mantle cell lymphoma comes a day before the drug was listed among the ...

In a report released on January 15, David Evans from Kepler Capital maintained a Hold rating on AstraZeneca (AZN – Research Report), with a ...

DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based ...

A crypto investor shares how AI agents drive innovation and new opportunities in the blockchain space. Diversification and ...

Shares of AstraZeneca PLC AZN rallied 1.84% to £108.44 Thursday, on what proved to be an all-around positive trading session ...

AstraZeneca share rose after it that the company has secured permission to import pharmaceutical formulations of new drug for ...

Mina Makar highlights AstraZeneca's commitment to advancing heart failure research and innovative therapies, addressing ...

Shares of AstraZeneca PLC AZN inched up 0.17% to £106.48 Wednesday, on what proved to be an all-around positive trading ...